Protara Therapeutic Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.21

-0.09 (-1.70%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +349.9% upside

Low Target $15.10

Average Target $23.44

High Target $28.04

Current Price $5.21

Current
$5.21

Target
$23.44

$15.10 $23.44 avg $28.04

Scenario Analysis

Bear Case

$15.10

189.8%

Low target

Base Case

$23.44

+349.9%

Avg target

Bull Case

$28.04

+438.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$7.82

-33.4% from high

52-Week Low

$2.77

+88.1% from low

Target vs 52W High

$23.44

+199.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%